Utilization of induced pluripotent stem cells to model the molecular network regulating congenital heart disease.
作者信息
Mullen McKay M S, Wu Joseph C
机构信息
Stanford Cardiovascular Institute, 240 Pasteur Drive, Room 3200, Palo Alto, CA, 94305, USA.
出版信息
Cardiovasc Res. 2022 Feb 21;118(3):664-666. doi: 10.1093/cvr/cvab373.
Abstract
摘要
相似文献
1
Utilization of induced pluripotent stem cells to model the molecular network regulating congenital heart disease.利用诱导多能干细胞构建调控先天性心脏病的分子网络模型。
Cardiovasc Res. 2022 Feb 21;118(3):664-666. doi: 10.1093/cvr/cvab373.
2
Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.从患者特异性诱导多能干细胞衍生的心肌细胞构建的工程化心脏组织的单细胞转录组学揭示了右心发育不全综合征中的异常发育轨迹和内在收缩缺陷。
J Am Heart Assoc. 2020 Oct 20;9(20):e016528. doi: 10.1161/JAHA.120.016528. Epub 2020 Oct 16.
3
RNA Sequencing Analysis of Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Congenital Heart Disease Patients.先天性心脏病患者诱导多能干细胞来源心肌细胞的RNA测序分析
Circ Res. 2020 Mar 27;126(7):923-925. doi: 10.1161/CIRCRESAHA.119.315653. Epub 2020 Feb 19.
4
iPSC model of congenital heart disease predicts disease outcome.iPSC 模型预测先天性心脏病的疾病结局。
Cell Stem Cell. 2022 May 5;29(5):659-660. doi: 10.1016/j.stem.2022.04.010.
5
Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.接种人诱导多能干细胞来源心肌细胞的组织工程心脏补片促进了大鼠模型中宿主心肌细胞的再生。
J Cardiothorac Surg. 2016 Dec 1;11(1):163. doi: 10.1186/s13019-016-0559-z.
6
Modeling Congenital Heart Disease Using Pluripotent Stem Cells.使用多能干细胞建立先天性心脏病模型。
Curr Cardiol Rep. 2020 Jun 19;22(8):55. doi: 10.1007/s11886-020-01316-y.
7
From Stem Cells to Populations-Using hiPSC, Next-Generation Sequencing, and GWAS to Explore the Genetic and Molecular Mechanisms of Congenital Heart Defects.从干细胞到群体——利用 hiPSC、下一代测序和 GWAS 探索先天性心脏病的遗传和分子机制。
Genes (Basel). 2021 Jun 16;12(6):921. doi: 10.3390/genes12060921.
8
Alternative splicing signatures of congenital heart disease and induced pluripotent stem cell-derived cardiomyocytes from congenital heart disease patients.先天性心脏病的选择性剪接特征和先天性心脏病患者诱导多能干细胞衍生的心肌细胞。
Medicine (Baltimore). 2022 Aug 19;101(33):e30123. doi: 10.1097/MD.0000000000030123.
9
Abnormal Progenitor Cell Differentiation and Cardiomyocyte Proliferation in Hypoplastic Right Heart Syndrome.右心发育不全综合征中祖细胞分化异常与心肌细胞增殖
Circulation. 2024 Mar 12;149(11):888-891. doi: 10.1161/CIRCULATIONAHA.123.064213. Epub 2024 Mar 11.
10
Induced Pluripotent Stem Cell-Based Modeling of Single-Ventricle Congenital Heart Diseases.基于诱导多能干细胞的单心室先天性心脏病建模。
Curr Cardiol Rep. 2023 May;25(5):295-305. doi: 10.1007/s11886-023-01852-3. Epub 2023 Mar 17.
引用本文的文献
1
SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3β/β-catenin&ERK signaling.SMYD1 通过 GSK3β/β-catenin&ERK 信号通路调节人多能干细胞来源的多能心脏祖细胞在心肌分化过程中的增殖。
Stem Cell Res Ther. 2024 Oct 8;15(1):350. doi: 10.1186/s13287-024-03899-7.
本文引用的文献
1
Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect.患者特异性 iPSC 衍生心肌细胞揭示家族性房间隔缺损中 FGF16 的异常调节。
Cardiovasc Res. 2022 Feb 21;118(3):859-871. doi: 10.1093/cvr/cvab154.
2
FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer.受miR-520b调控的FGF16增强肺癌细胞增殖。
Open Med (Wars). 2021 Mar 15;16(1):419-427. doi: 10.1515/med-2021-0232. eCollection 2021.
3
Race and Genetics in Congenital Heart Disease: Application of iPSCs, Omics, and Machine Learning Technologies.先天性心脏病中的种族与遗传学：诱导多能干细胞、组学及机器学习技术的应用
Front Cardiovasc Med. 2021 Feb 17;8:635280. doi: 10.3389/fcvm.2021.635280. eCollection 2021.
4
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association.人诱导多能干细胞衍生心肌细胞在临床前癌症药物心脏毒性检测中的应用：美国心脏协会的科学声明。
Circ Res. 2019 Oct 25;125(10):e75-e92. doi: 10.1161/RES.0000000000000291. Epub 2019 Sep 19.
5
CRISPR Craze to Transform Cardiac Biology.CRISPR 热潮正在改变心脏生物学。
Trends Mol Med. 2019 Sep;25(9):791-802. doi: 10.1016/j.molmed.2019.06.008. Epub 2019 Jul 17.
6
Socioeconomic Mediators of Racial and Ethnic Disparities in Congenital Heart Disease Outcomes: A Population-Based Study in California.社会经济因素在先天性心脏病结局中的种族和民族差异的中介作用：加利福尼亚州的一项基于人群的研究。
J Am Heart Assoc. 2018 Oct 16;7(20):e010342. doi: 10.1161/JAHA.118.010342.
7
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?iPSC 心肌细胞会给心脏病药物研发带来革命性变化吗？
Curr Opin Pharmacol. 2018 Oct;42:55-61. doi: 10.1016/j.coph.2018.07.003. Epub 2018 Aug 3.
8
Human stem cells for modeling heart disease and for drug discovery.用于心脏病建模和药物研发的人类干细胞。
Sci Transl Med. 2014 Jun 4;6(239):239ps6. doi: 10.1126/scitranslmed.3008921.
9
Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.利用锌指核酸酶对人类胚胎干细胞和诱导多能干细胞进行基因组编辑，用于细胞成像。
Circ Res. 2012 Dec 7;111(12):1494-503. doi: 10.1161/CIRCRESAHA.112.274969. Epub 2012 Sep 11.
10
A novel mutation of GATA4 in a familial atrial septal defect.GATA4 基因家族性房间隔缺损的一种新突变。
Clin Chim Acta. 2010 Nov 11;411(21-22):1741-5. doi: 10.1016/j.cca.2010.07.021. Epub 2010 Jul 24.
Zotero 插件